Disease phenotype | Item in this table | Key references | Gene symbol (chromosome)
protein | All allelic disease phenotypes - locus/disease symbols |
Congenital muscular dystrophy with merosin deficient - (AR) | 2.1 | | | Laminin alpha 2 chain of merosin
|
|
| | * Muscular dystrophy, congenital merosin-deficient - MDC1A | | * LGMDR23 |
|
Bethlem myopathy 1 - (AD) | 2.2 | | | | * Bethlem myopathy | | * Ullrich congenital muscular dystrophy - UCMD1 | | * LGMDR22 | | * LGMDD5 |
|
Bethlem myopathy 1 - (AD) | 2.3 | | | | * myosclerosis, autosomal recessive | | * LGMDR22 | | * LGMDD5 | | * Bethlem myopathy | | * Ullrich scleroatonic muscular dystrophy - UCMD1 |
|
Bethlem myopathy 1 - (AR) | 2.4 | | | | * myosclerosis, autosomal recessive | | * LGMDR22 | | * LGMDD5 | | * Bethlem myopathy | | * Ullrich scleroatonic muscular dystrophy - UCMD1 | | * LGMDR22 | | * LGMDD5 | | * Bethlem myopathy | | * Ullrich congenital muscular dystrophy - UCMD1 |
|
Bethlem myopathy 1 - (AR) | 2.5 | | | | * myosclerosis, autosomal recessive | | * LGMDR22 | | * LGMDD5 | | * Bethlem myopathy | | * Ullrich scleroatonic muscular dystrophy - UCMD1 |
|
Ullrich congenital muscular dystrophy 1 - (AR) | 2.6 | | | | * Bethlem myopathy | | * Ullrich congenital muscular dystrophy - UCMD1 | | * LGMDR22 | | * LGMDD5 |
|
Ullrich congenital muscular dystrophy 1 - (AD) | 2.7 | | | | * myosclerosis, autosomal recessive | | * LGMDR22 | | * LGMDD5 | | * Bethlem myopathy | | * Ullrich scleroatonic muscular dystrophy - UCMD1 |
|
Ullrich congenital muscular dystrophy 1 - (AR) | 2.8 | | | | * LGMDR22 | | * LGMDD5 | | * Bethlem myopathy | | * Ullrich congenital muscular dystrophy - UCMD1 |
|
Ullrich congenital muscular dystrophy 2 - (AR) | 2.9 | | | Collagen type XII alpha 1 chain
|
|
| | * Ullrich congenital muscular dystrophy 2 - UCMD2 | | * Bethlem myopathy 2 - BTHLM2 | | * COL12A1-related congenital muscular dystrophy |
|
Bethlem myopathy 2 - (AD) | 2.10 | | | Collagen type XII alpha 1 chain
|
|
| | * Ullrich congenital muscular dystrophy 2 - UCMD2 | | * Bethlem myopathy 2 - BTHLM2 | | * COL12A1-related congenital muscular dystrophy |
|
COL12A1-related congenital muscular dystrophy - (AD) | 2.11 | | | Collagen type XII alpha 1 chain
|
|
| | * Ullrich congenital muscular dystrophy 2 - UCMD2 | | * Bethlem myopathy 2 - BTHLM2 | | * COL12A1-related congenital muscular dystrophy |
|
Myosclerosis, congenital - (AR) | 2.12 | | | | * myosclerosis, autosomal recessive | | * LGMDR22 | | * LGMDD5 | | * Bethlem myopathy | | * Ullrich scleroatonic muscular dystrophy - UCMD1 |
|
Rigid spine syndrome 1 - (AR) | 2.13 | | | | * Multiminicore disease, classical form | | * myopathy, congenital, with fiber-type disproportion - CFTD | | * Rigid spine syndrome related to SEPN1 - RSS | | * Rigid spine syndrome - RSMD1 | | * Muscular dystrophy, rigid spine, 1 - RSMD1 | | * Desmin-related myopathy with Mallory bodies - RSMD1 |
|
Congenital muscular dystrophy due to ITGA7 deficiency - (AR) | 2.14 | | | Integrin alpha 7 precursor
|
|
| | * Congenital muscular dystrophy with integrin defect | | * Muscular dystrophy, congenital, due to ITGA7 deficiency |
|
Congenital muscular dystrophy related to DNM2 - (AD) | 2.15 | | | | * Charcot-Marie-Tooth disease, dominant intermediate B - CMTDIB | | * Myopathy centronuclear, 1 - CNM1 | | * Lethal Congenital Contracture Syndrome 5 - LCCS5 |
|
Congenital musuclar dystrophy related to TCAP - (AR) | 2.16 | | | | * Dilated cardiomyopathy, 1N | | * Congenital musuclar dystrophy with telethonin defect | | * Hypertrophic cardiomyopathy related to TCAP - CMH25 | | * Muscular dystrophy, limb-girdle, type 2G - LGMD2G |
|
Congenital muscular dystrophy related to LMNA - (AD) | 2.17 | | | | * Charcot-Marie-Tooth disease, axonal, type 2B1 - CMT2B1 | | * Hutchinson-Gilford progeria syndrome - HGPS | | * Mandibuloacral dysplasia with type a lipodystrophy - MADA | | * restrictive dermopathy | | * Lipodystrophy, familial partial, type 2 - FPLD2 | | * Cardiomyopathy, dilated, 1A - CMD1A | | * Congenital muscular dystrophy due to LMNA defect (L-CMD) | | * Emery-Dreifuss muscular dystrophy, autosomal dominant - EDMD2 | | * Emery-Dreifuss Autosomal recessive - EDMD3 | | * Muscular dystrophy, limb-girdle, type 1B - LGMD1B |
|
Disease phenotype | Item in this table | Key references | Gene symbol (chromosome)
protein | All allelic disease phenotypes - locus/disease symbols |
Muscular dystrophy-dystroglycanopathy (Congenital with brain and eyes anomlies), type A1 - (AR) | 2.18 | | | Protein-O-mannosyltransferase 1
|
|
| | * Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), - MDDGA1 | | * Muscular dystrophy, Limb-Girdle, type 2K - LGMD2K | | * Muscular dystrophy-dystrooglycanopathy (congenital with mental retardation), type B1 - MDDGB1 | | * Walker-Warburg syndrome - WWS |
|
Muscular dystrophy-dystroglycanopathy (Congenital with brain and eyes anomlies), type A2 - (AR) | 2.19 | | | Protein-O-mannosyltransferase 2
|
|
| | * Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), - MDDGA2 | | * Walker-Warburg syndrome - WWS | | * Limb-girdle, muscular dystrophy, type 2n - LGMD2N | | * Muscle-eye-brain disease - MEB |
|
Muscular dystrophy-dystroglycanopathy (Congenital with brain and eyes anomlies), type A3 - (AR) | 2.20 | | | O-linked mannose beta1,2-N-acetylglucosaminyltransferase
|
|
| | * Limb-girdle, muscular dystrophy, type 2o - LGMD2O | | * Muscular dystrophy, limb-girdle, autosomal recessive 15 - LGMDR15 | | * Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type - MDDGB3 | | * Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), - MDDGA3 |
|
Muscular dystrophy-dystroglycanopathy (Congenital with brain and eyes anomlies), type A4 - (AR) | 2.21 | | | | * Walker-Warburg syndrome - WWS | | * Muscular dystrophy-dystroglycanopathy (congenital without mental retardation), t - MDDGB4 | | * fukuyama congenital muscular dystrophy - FCMD | | * Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), - MDDGA4 | | * Cardiomyopathy, dilated, 1X - CMD1X | | * Limb-Girdle, Muscular dystrophy, type 2M - LGMD2M |
|
Muscular dystrophy-dystroglycanopathy (Congenital with brain and eyes anomlies), type A5 - (AR) | 2.22 | | | | * Walker-Warburg syndrome - WWS | | * Muscle-eye-brain disease - MEB | | * Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), - MDDGA5 | | * Muscular dystrophy-dystroglycanopathy (congenital with or without mental retarda - MDDGB5 | | * Muscular dystrophy, limb-girdle, type 2I - LGMD2I |
|
Muscular dystrophy-dystroglycanopathy (Congenital with brain and eyes anomlies), type A6 - (AR) | 2.23 | | | LARGE xylosyl- and glucuronyltransferase 1
|
|
| | * Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type - MDDGB6 | | * Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), - MDDGA6 |
|
Muscular dystrophy-dystroglycanopathy (Congenital with brain and eyes anomlies), type A7 - (AR) | 2.24 | | | Isoprenoid synthase domain containing protein
|
|
| | * LGMDR20 - LGMDR20 | | * Walker-Warburg syndrome (WWS) - MDDGA7 |
|
Muscular dystrophy-dystroglycanopathy (Congenital with brain and eyes anomlies), type A8 - (AR) | 2.25 | | | protein O-linked mannose N-acetylglucosaminyltransferase 2
|
|
| | * Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, - MDDGA8 | | * Walker-Warburg syndrome - WWS | | * LGMDR24 |
|
Muscular dystrophy-dystroglycanopathy (Congenital with brain and eyes anomlies), type A9 - (AR) | 2.26 | | | | * Muscular dystrophy-dystroglycanopathy (limb-girdle) - MDDGC9 | | * Congenital muscular dystrophy with hypoglycosylation of dystroglycan type A9 - MDDGA9 |
|
Muscular dystrophy-dystroglycanopathy (Congenital with brain and eyes anomlies), type A10 - (AR) | 2.27 | | | Ribitol xylosyltransferase 1 (transmembrane protein 5)
|
|
| | * Congenital muscular dystrophy with hypoglycosylation of dystroglycan type A10 - MDGGA10 |
|
Muscular dystrophy-dystroglycanopathy (Congenital with brain and eyes anomlies), type A11 - (AR) | 2.28 | | | Beta-1,3-N-acetylgalacto-saminyltransferase 2
|
|
| | * Congenital muscular dystrophy with hypoglycosylation of dystroglycan WWWS/MEB li - MDDGA11 |
|
Muscular dystrophy-dystroglycanopathy (Congenital with brain and eyes anomlies), type A12 - (AR) | 2.29 | | | | * Congenital muscular dystrophy with hypoglycosylation of dystroglycan type A,12 - MDDGA12 | | * Muscular dystrophy-dystroglycanopathy (Limb-girdle), type C12 - MDDGC12 |
|
Muscular dystrophy-dystroglycanopathy (Congenital with brain and eyes anomlies), type A13 - (AR) | 2.30 | | | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyl-transferase 1
|
|
| | * Walker-Warburg syndrome (WWS) - MDDGA13 |
|
Muscular dystrophy-dystroglycanopathy (Congenital with brain and eyes anomlies), type A14 - (AR) | 2.31 | | | GDP-mannose pyrophosphorylase B
|
|
| | * Muscle-eye-brain disease - MDDGA14 | | * Limb-Girdle, Muscular dystrophy, type 2T - MDDGC14 | | * Congenital Myasthenic syndrome related to GMPPB |
|
Muscular dystrophy-dystrooglycanopathy (congenital with mental retardation), type B1 - (AR) | 2.32 | | | Protein-O-mannosyltransferase 1
|
|
| | * Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), - MDDGA1 | | * Muscular dystrophy, Limb-Girdle, type 2K - LGMD2K | | * Muscular dystrophy-dystrooglycanopathy (congenital with mental retardation), type B1 - MDDGB1 | | * Walker-Warburg syndrome - WWS |
|
Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B2 - (AR) | 2.33 | | | Protein-O-mannosyltransferase 2
|
|
| | * Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), - MDDGA2 | | * Walker-Warburg syndrome - WWS | | * Limb-girdle, muscular dystrophy, type 2n - LGMD2N | | * Muscle-eye-brain disease - MEB |
|
Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B3 - (AR) | 2.34 | | | O-linked mannose beta1,2-N-acetylglucosaminyltransferase
|
|
| | * Limb-girdle, muscular dystrophy, type 2o - LGMD2O | | * Muscular dystrophy, limb-girdle, autosomal recessive 15 - LGMDR15 | | * Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type - MDDGB3 | | * Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), - MDDGA3 |
|
Muscular dystrophy-dystroglycanopathy (congenital without impaired intellectual development), type B4 - (AR) | 2.35 | | | | * Walker-Warburg syndrome - WWS | | * Muscular dystrophy-dystroglycanopathy (congenital without mental retardation), t - MDDGB4 | | * fukuyama congenital muscular dystrophy - FCMD | | * Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), - MDDGA4 | | * Cardiomyopathy, dilated, 1X - CMD1X | | * Limb-Girdle, Muscular dystrophy, type 2M - LGMD2M |
|
Muscular dystrophy-dystroglycanopathy (congenital with or without impaired intellectual development), type B5 - (AR) | 2.36 | | | | * Walker-Warburg syndrome - WWS | | * Muscle-eye-brain disease - MEB | | * Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), - MDDGA5 | | * Muscular dystrophy-dystroglycanopathy (congenital with or without mental retarda - MDDGB5 | | * Muscular dystrophy, limb-girdle, type 2I - LGMD2I |
|
Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B6 - (AR) | 2.37 | | | LARGE xylosyl- and glucuronyltransferase 1
|
|
| | * Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type - MDDGB6 | | * Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), - MDDGA6 |
|
Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B14 - (AR) | 2.38 | | | GDP-mannose pyrophosphorylase B
|
|
| | * Muscle-eye-brain disease - MDDGA14 | | * Limb-Girdle, Muscular dystrophy, type 2T - MDDGC14 | | * Congenital Myasthenic syndrome related to GMPPB |
|
Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B15 - (AR) | 2.39 | | | Dolichyl-phosphate mannosyltransferase polypeptide 3
|
|
| | * Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B15 - MDDGB15 | | * Muscle dystrophy with congenital disorder of glycosylation, type Io - CDG1O |
|
Muscle-eye-brain disease (MEB) - (AD) | 2.40 | | | |
Congenital disorder of glycosylation, type Ie - (AR) | 2.41 | | | Dolichyl-phosphate mannosyltransferase 1, catalytic subunit
|
|
| | * Congenital muscular dystrophy with hypoglycosylation of dystroglycan - CDG1E |
|
Congenital disorder of glycosylation, type 1f - (AR) | 2.42 | | | Mannose-P-dolichol utilization defect 1
|
|
| | * Congenital disorder of glycosylation type 1 - CDG1F |
|
Congenital disorder of glycosylation, type 1u - (AR) | 2.43 | | | Dolichyl-phosphate mannosyltransferase polypeptide 2, regulatory subunit
|
|
| | * Muscle dystrophy with congenital disorder of glycosylation | | * Congenital muscular dystrophy and abnormal glycosylation of dystroglycan with se |
|
Disease phenotype | Item in this table | Key references | Gene symbol (chromosome)
protein | All allelic disease phenotypes - locus/disease symbols |
Congenital muscle dystrophy with mitochondrial structural abnormalities (megaconial type) - (AR) | 2.44 | | | | * Congenital muscle dystrophy with mitochondrial structural abnormalities - MDCMC |
|
Congenital muscular dystrophy - (AR) | 2.45 | | | | * Congenital muscular dystrophy - MDC1B | | * Congenital muscular dystrophy with merosin deficiency - MDC1B |
|
Developmental delay with hypotonia, myopathy and brain abnormalities - (AR) | 2.46 | | | | * Developmental delay with hypotonia, myopathy and brain abnormalities - DEDHMB |
|
Muscular dystrophy, congenital Davignon-Chauveau type - (AR) | 2.47 | | | Thyroid hormone receptor interactor 4
|
|
| | * Muscular dystrophy, congenital Davignon-Chauveau type - MDCD | | * Spinal muscular atrophy with congenital bone fractures 1 - SMABF1 |
|
Muscular dystrophy, congenital, with cataracts and intellectual disability - (AR) | 2.48 | | | Inositol Polyphosphate-5-Phosphatase K
|
|
| | * Muscular dystrophy, congenital, with cataracts and intellectual disability - MDCCAID |
|
Congenital muscular dystrophy related to MSTO1 - (AR) | 2.49 | | | Misato homolog 1 (Drosophila)(M)
|
|
| | * Myopathy, mitochondrial and cerebellar ataxia - MMYAT |
|
Congenital muscular dystrophy related to RYR1 | 2.50 | | | Ryanodine receptor 1 (skeletal)
|
|
| | * centronuclear myopathy, recessive | | * minicore myopathy with external ophthalmoplegia | | * myopathy, congenital, with fiber-type disproportion - CFTD | | * Fetal akinesia deformation sequence related to RYR1 | | * Dusty core disease related to RYR1 - DuCD | | * Congenital myopathy 1A, dominant, with susceptibility to malignant hyperthermia - CMYP1A | | * Congenital myopathy 1B, recessive - CMYP1B | | * Malignant hyperthermia susceptibility 1 - MHS1 | | * Central core disease - CCD |
|
Congenital muscular dystrophy with fatty liver and infantile-onset cataract caused by TRAPPC11 mutations - (AR) | 2.51 | | | Trafficking protein particle complex 11
|
|
| | * Limb-Girdle, Muscular dystrophy, type 2S - LGMD2S | | * Congenital muscular dystrophy with fatty liver and infantile-onset cataract caused by TRAPPC11 mutations: broadening of the phenotype - CMD |
|
Congenital muscular dystrophy, with ou without seizures - (AR) | 2.52 | | | Golgi SNAP receptor complex member 2
|
|
| | * Muscular dystrophy related to GOSR2 - GOSR2 |
|
Congenital muscular dystrophy with epilepsy - (AR) | 2.53 | | | BET1 golgi vesicular membrane-trafficking protein
|
|
| | * Congenital muscular dystrophy with epilepsy |
|
Congenital muscular dystrophy related to TRAPPC2L - (AR) | 2.54 | | | Trafficking protein particle complex 2-like
|
|
| | * Congenital muscular dystrophy related to TRAPPC2L |
|